DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
JUNE 5-6, 1980 
The Recombinant DNA Advisory Committee (RAC) was convened for its nineteenth 
meeting at 9 a.m. on June 5, 1980, in Conference Room 6, Building 31C, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20205. Dr. Jane K. 
Setlow (Chairman), Biologist, Brookhaven National Laboratory, presided. In 
accordance with Public Law 92-463 the meeting was open to the public, except 
for the review of proposals involving proprietary information as the last item 
of business on June 6, 1980. 
Committee members present for all or part of the meeting were : 
Dr. Abdul Karim Ahmed; Dr. David Baltimore; Dr. Kenneth Bems, Dr. Winston Brill; 
Dr. Francis Broadbent; Dr. Allan Campbell; Mrs. Zelma Cason; Dr. Richard Goldstein; 
Dr. Susan Gottesman; Ms. Patricia King; Dr. Sheldon Krimsky; Dr. Werner Maas; 
Dr. Elena Nightingale; Dr. Richard Novick; Dr. David Parkinson; Mr. Ray Thornton; 
Dr. LePoy Walters; Dr. Luther Williams; Dr. Frank Young; Dr. Milton Zaitlin; 
and Dr. William J. Gartland, Jr., Executive Secretary. 
A Committee roster is attached. (Attachment I) 
The following ad hoc consultants to the Committee were present : 
Mr. Glenwood Achom, Higdon, Arkansas; Dr. Gerald Fink, Cornell University, 
Ithaca, New York; Dr. Elmer Gaden, University of Virginia, Charlottesville, 
Virginia; Dr. Myron Levine, University of Maryland School of Medicine, Baltimore, 
Maryland; Dr. Gerard McGarrity, Institute for Medical Research, Camden, New Jersey; 
Dr. Robert McKinney, Enviro Control, Inc., Rsckville, Maryland; and Dr. John 
Scandal ios. North Carolina State University, North Carolina. 
1 The RAC is advisory to the NIH, and its recommendations should not 
be considered as final and accepted. The Office of Recombinant DNA 
Activities should be consulted for NIH policy on specific issues. 
[ 101 ] 
